Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Piperazine- and piperidine-derivatives as melanocortin receptor agonists

Piperazine- and piperidine-derivatives as melanocortin receptor agonists

US Patent 7186715 · Granted Mar 6, 2007

Estimated economic value: $170,937,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-N-2024
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-2023
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2023
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benz2023
Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors2022
[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes2022
[1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives2021
Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benz2021
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK2021
Compounds useful for inhibiting RORγt2021
Compounds useful for inhibiting ROR-gamma-t2020
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2019